Skip to main content

Advertisement

SpringerLink
Log in

CYP17 polymorphism (rs743572) is associated with increased risk of gallbladder cancer in tobacco users

  • Research Article
  • Published:
Tumor Biology

Abstract

Gallbladder cancer (GBC) involves interplay of sex steroids, including estrogen and progesterone. Since CYP17 is a key enzyme involved in estrogen and testosterone hormone biosynthesis as well as in xenobiotic metabolism, it may be a potential candidate gene in the carcinogenesis of the gallbladder. Hence, the present study aimed to investigate the association of CYP17 (rs2486758, and rs743572) polymorphisms with GBC susceptibility. The present study included a total of 414 histologically confirmed GBC and 230 healthy controls. The CYP17 (rs2486758 and rs743572) polymorphisms were genotyped by TaqMan-Allele discrimination assays. Statistical analysis was performed by using SPSS ver. 16. Overall, both the CYP17 SNPs did not indicate any association with GBC risk at genotype, haplotype, or at the genotypic interaction levels. However, in the case-only analysis, CYP rs743572 showed association with increased risk of GBC in tobacco users at hetero genotype and dominant models, as compared to non-user GBC patients. The TCrs2486758-AGrs743572 genotypic combination was also associated with increased GBC susceptibility in tobacco users. CYP17 rs743572 is associated with increased risk of GBC in tobacco users in the North Indian population. However, the study requires confirmation in other populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

GBC:

Gallbladder cancer

HC:

Healthy controls

SNP:

Single nucleotide polymorphism

SPSS:

Statistical package for social sciences

OR:

Odds ratio

CI:

Confidence interval

HWE:

Hardy–Weinberg equilibrium

References

  1. Wang F, Wang B, Qiao L. Association between obesity and gallbladder cancer. Front Biosci (Landmark Ed). 2012;17:2550–8.

    Article  Google Scholar 

  2. Misra S, Chaturvedi A, Misra NC. Gallbladder cancer. Curr Treat Options Gastroenterol. 2006;9:95–106.

    Article  PubMed  Google Scholar 

  3. Sheth S, Bedford A, Chopra S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am J Gastroenterol. 2000;95:1402–10.

    Article  CAS  PubMed  Google Scholar 

  4. Baez S, Tsuchiya Y, Calvo A, Pruyas M, Nakamura K, Kiyohara C, et al. Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women. World J Gastroenterol. 2010;16:372–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Tsuchiya Y, Terao M, Okano K, Nakamura K, Oyama M, Ikegami K, et al. Mutagenicity and mutagens of the red chili pepper as gallbladder cancer risk factor in Chilean women. Asian Pac J Cancer Prev. 2011;12:471–6.

    PubMed  Google Scholar 

  6. Dwivedi S, Madeshiya A, Singh D, Singh S, Krishna A. Gall bladder cancer and some epidemiological factors: a cross sectional study. Biomed Res. 2013;24:83–7.

    Google Scholar 

  7. Gabbi C, Kim HJ, Barros R, Korach-Andre M, Warner M, Gustafsson JA. Estrogen-dependent gallbladder carcinogenesis in lxrbeta−/− female mice. Proc Natl Acad Sci U S A. 2010;107:14763–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Srivastava A, Sharma KL, Srivastava N, Misra S, Mittal B. Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PLoS One. 2012;7:e40162.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Xu J, Lin X, Zhu H, Zhang Z, Yang B. Genetic variation of the cyp17 and susceptibility to endometrial cancer: a meta-analysis. Mol Biol Rep. 2013;40:5085–91.

    Article  CAS  PubMed  Google Scholar 

  10. Sakoda LC, Blackston C, Doherty JA, Ray RM, Lin MG, Stalsberg H, et al. Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women. Cancer Epidemiol Biomarkers Prev. 2008;17:1066–73.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Stanford JL, Noonan EA, Iwasaki L, Kolb S, Chadwick RB, Feng Z, et al. A polymorphism in the cyp17 gene and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2002;11:243–7.

    CAS  PubMed  Google Scholar 

  12. Tuzuner BM, Ozturk T, Kisakesen HI, Ilvan S, Zerrin C, Ozturk O, et al. Cyp17 (t-34c) and cyp19 (trp39arg) polymorphisms and their cooperative effects on breast cancer susceptibility. In Vivo. 2010;24:71–4.

    CAS  PubMed  Google Scholar 

  13. Iversen A, Thune I, McTiernan A, Makar KW, Wilsgaard T, Ellison PT, et al. Genetic polymorphism cyp17 rs2486758 and metabolic risk factors predict daily salivary 17beta-estradiol concentration in healthy premenopausal Norwegian women. The EBBA-I study. J Clin Endocrinol Metab. 2012;97:E852–7.

    Article  CAS  PubMed  Google Scholar 

  14. Chakraborty A, Murthy NS, Chintamani C, Bhatnagar D, Mohil RS, Sharma PC, et al. Cyp17 gene polymorphism and its association with high-risk North Indian breast cancer patients. J Hum Genet. 2007;52:159–65.

    Article  PubMed  Google Scholar 

  15. Surekha D, Sailaja K, Rao DN, Padma T, Raghunadharao D, Vishnupriya S. Association of a cyp17 gene polymorphism with development of breast cancer in India. Asian Pac J Cancer Prev. 2010;11:1653–7.

    CAS  PubMed  Google Scholar 

  16. Yazici H, Tigli H, Kadehci Z, Kucucuk S, Saip P, Issever H, et al. Are cyp17 genotypes a biomarker for ovarian cancer in patients with cancer history in their family? Oncol Res. 2006;16:43–7.

    CAS  PubMed  Google Scholar 

  17. Hou L, Xu J, Gao YT, Rashid A, Zheng SL, Sakoda LC, et al. Cyp17 mspa1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China. Int J Cancer. 2006;118:2847–53.

    Article  CAS  PubMed  Google Scholar 

  18. Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Laird NM, Khuhaprema T, et al. Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. Int J Cancer. 2009;125:837–43.

    Article  CAS  PubMed  Google Scholar 

  19. Sushko TA, Gilep AA, Usanov SA. Genetics, structure, function, mode of actions and role in cancer development of cyp17. Anticancer Agents Med Chem. 2014;14:66–76.

    Article  CAS  PubMed  Google Scholar 

  20. Yang X, Feng A, Liu F, Li Q, Zhang J, Yang C, et al. Cyp17a1 t-34c polymorphism is not associated with endometrial cancer risk. Tumour Biol. 2013;34:2583–7.

    Article  CAS  PubMed  Google Scholar 

  21. Cote ML, Yoo W, Wenzlaff AS, Prysak GM, Santer SK, Claeys GB, et al. Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis. 2009;30:626–35.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Rai R, Sharma KL, Tiwari S, Misra S, Kumar A, Mittal B. Dcc (deleted in colorectal carcinoma) gene variants confer increased susceptibility to gallbladder cancer (ref. No.: Gene-d-12-01446). Gene. 2013;518:303–9.

    Article  CAS  PubMed  Google Scholar 

  23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Hassanzadeh J, Moradzadeh R, Rajaee Fard A, Tahmasebi S, Golmohammadi P. A comparison of case-control and case-only designs to investigate gene-environment interactions using breast cancer data. Iran J Med Sci. 2012;37:112–8.

    PubMed Central  PubMed  Google Scholar 

  25. Jain M, Kumar S, Lal P, Tiwari A, Ghoshal UC, Mittal B. Role of GSTM3 polymorphism in the risk of developing esophageal cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:178–81.

    Article  CAS  PubMed  Google Scholar 

  26. Fan YS, Sasi R, Lee C, Winter JS, Waterman MR, Lin CC. Localization of the human cyp17 gene (cytochrome p450(17 alpha)) to 10q24.3 by fluorescence in situ hybridization and simultaneous chromosome banding. Genomics. 1992;14:1110–1.

    Article  CAS  PubMed  Google Scholar 

  27. Hong CC, Thompson HJ, Jiang C, Hammond GL, Tritchler D, Yaffe M, et al. Association between the t27c polymorphism in the cytochrome p450 c17alpha (cyp17) gene and risk factors for breast cancer. Breast Cancer Res Treat. 2004;88:217–30.

    Article  CAS  PubMed  Google Scholar 

  28. Olson SH, Bandera EV, Orlow I. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a huge review. Am J Epidemiol. 2007;165:235–45.

    Article  PubMed  Google Scholar 

  29. Lurie G, Maskarinec G, Kaaks R, Stanczyk FZ, Le Marchand L. Association of genetic polymorphisms with serum estrogens measured multiple times during a 2-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2005;14:1521–7.

    Article  CAS  PubMed  Google Scholar 

  30. Chattopadhyay S, Siddiqui S, Akhtar MS, Najm MZ, Deo SV, Shukla NK, et al. Genetic polymorphisms of esr1, esr2, cyp17a1, and cyp19a1 and the risk of breast cancer: a case control study from North India. Tumour Biol. 2014. doi:10.1007/s13277-013-1594-1

  31. Souiden Y, Mahdouani M, Chaieb K, Elkamel R, Mahdouani K. Cyp17 gene polymorphism and prostate cancer susceptibility in a Tunisian population. Cancer Epidemiol. 2011;35:480–4.

    Article  CAS  PubMed  Google Scholar 

  32. Taioli E, Sears V, Watson A, Flores-Obando RE, Jackson MD, Ukoli FA, et al. Polymorphisms in cyp17 and cyp3a4 and prostate cancer in men of African descent. Prostate. 2013;73:668–76.

    Article  CAS  PubMed  Google Scholar 

  33. Nedelcheva Kristensen V, Haraldsen EK, Anderson KB, Lonning PE, Erikstein B, Karesen R, et al. Cyp17 and breast cancer risk: the polymorphism in the 5′ flanking area of the gene does not influence binding to sp-1. Cancer Res. 1999;59:2825–8.

    CAS  PubMed  Google Scholar 

  34. Mao C, Wang XW, He BF, Qiu LX, Liao RY, Luo RC, et al. Lack of association between cyp17 mspa1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls. Breast Cancer Res Treat. 2010;122:259–65.

    Article  CAS  PubMed  Google Scholar 

  35. Severi G, Hayes VM, Tesoriero AA, Southey MC, Hoang HN, Padilla EJ, et al. The rs743572 common variant in the promoter of cyp17a1 is not associated with prostate cancer risk or circulating hormonal levels. BJU Int. 2008;101:492–6.

    CAS  PubMed  Google Scholar 

  36. Gaudet MM, Lacey Jr JV, Lissowska J, Peplonska B, Brinton LA, Chanock S, et al. Genetic variation in cyp17 and endometrial cancer risk. Hum Genet. 2008;123:155–62.

    Article  CAS  PubMed  Google Scholar 

  37. Wang F, Zou YF, Feng XL, Su H, Huang F. Cyp17 gene polymorphisms and prostate cancer risk: a meta-analysis based on 38 independent studies. Prostate. 2011;71:1167–77.

    Article  CAS  PubMed  Google Scholar 

  38. Madigan MP, Gao YT, Deng J, Pfeiffer RM, Chang BL, Zheng S, et al. Cyp17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China. Int J Cancer. 2003;107:271–5.

    Article  CAS  PubMed  Google Scholar 

  39. Setiawan VW, Schumacher FR, Haiman CA, Stram DO, Albanes D, Altshuler D, et al. Cyp17 genetic variation and risk of breast and prostate cancer from the national cancer institute breast and prostate cancer cohort consortium (bpc3). Cancer Epidemiol Biomarkers Prev. 2007;16:2237–46.

    Article  CAS  PubMed  Google Scholar 

  40. Abate M, Vanni D, Pantalone A, Salini V. Cigarette smoking and musculoskeletal disorders. Muscles Ligaments Tendons J. 2013;3:63–9.

    PubMed Central  PubMed  Google Scholar 

  41. Tansavatdi K, McClain B, Herrington DM. The effects of smoking on estradiol metabolism. Minerva Ginecol. 2004;56:105–14.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the Department of Biotechnology and Indian Council of Medical Research, Government of India, for their financial support to carry out the present study.

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), Lucknow, 226014, Uttar Pradesh, India

    Rajani Rai, Kiran L. Sharma & Balraj Mittal

  2. Department of Surgical Oncology, KGMU, Lucknow, India

    Sanjeev Misra

  3. Department of Surgical Gastroenterology, Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), Lucknow, India

    Ashok Kumar

Authors
  1. Rajani Rai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kiran L. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sanjeev Misra
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ashok Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Balraj Mittal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Balraj Mittal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rai, R., Sharma, K.L., Misra, S. et al. CYP17 polymorphism (rs743572) is associated with increased risk of gallbladder cancer in tobacco users. Tumor Biol. 35, 6531–6537 (2014). https://doi.org/10.1007/s13277-014-1876-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-1876-2

Keywords

Search

Navigation